基础医学与临床 ›› 2014, Vol. 34 ›› Issue (7): 1006-1009.

• 短篇综述 • 上一篇    下一篇

肿瘤干细胞作为胰腺癌治疗潜在靶点的研究进展

孙宇,孙宁,杨绍时,宋国栋   

  1. 天津医科大学第二医院
  • 收稿日期:2014-04-14 修回日期:2014-05-17 出版日期:2014-07-05 发布日期:2014-06-24
  • 通讯作者: 孙宇 E-mail:bill19781206@163.com

Research progresses of cancer stem cells as Emerging targets in pancreatic cancer

  • Received:2014-04-14 Revised:2014-05-17 Online:2014-07-05 Published:2014-06-24
  • Contact: Yu SUN E-mail:bill19781206@163.com

摘要: 胰腺导管腺癌是最具侵袭性的肿瘤之一,对目前的治疗反应差和生存率低为其特点。最近肿瘤干细胞(CSC)在肿瘤生成中作用的研究进展使人们认识到CSC可作为新的治疗靶点。CSC是肿瘤细胞中一类明确的亚群,具有分化为其他细胞类型和为了保持肿瘤扩增而自我更新的能力。通过回顾CSC的生物标记和主要路径,似应找到以CSC为靶点的新的治疗方向。

关键词: 肿瘤干细胞 胰腺癌 上皮间质转换

Abstract: Pancreatic ductal adenocarcinoma is one of the most aggressive malignancies and is characterized by poor response to current therapy and a dismal survival rate. Recent insights regarding the role of cancer stem cells (CSC) in tumorigenesis have brought further understanding of the field and have highlighted new therapeutic targets. CSCs are a distinct subset of cancer cells, with the ability to differentiate into other cell types and self-renew in order to fuel the maintenance of tumor amplification. Here review the key pathways involved in these processes, the biomarkers used to identify CSC for finding new therapeutic approaches targeting CSC.

Key words: cancer stem cells,pancreatic ductal adenocarcinoma,epithelial–mesenchymal transition